A correct splicing of mRNA is globally required in all cells, but neurons seem highly sensitive to perturbations with numerous neurological diseases caused by splicing defects, including spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS), and dementias. Neurons have features that make them vulnerable to mis-splicing events, such as their postmitotic state and longevity. However, the reason of this peculiar sensitivity of neurons to splicing alterations, why only subclasses of neurons are affected and which step of RNA processing is impaired in these diseases is still debated. We are investigating the molecular mechanisms underlying the neurodegeneration caused by splicing defects in SMA, using a neuron specific silencing approach in C.elegans. SMA is a motor neurons (MNs) specific disorder caused by mutations in the Survival Motor Neuron (SMN) gene. RNA-sequencing of iPS-MNs from SMA patients and healthy people allowed us to identify differentially expressed/spliced genes, enriched in RNA motif 7 (CAAAAAG). This motif is specifically bound by hnRNPQ, a protein interacting with SMN in the SMN complex.
hrp-2 is the C.elegans homolog of hnRNPQ and we determined that, similarly to
smn-1(KO),
hrp-2 (
ok1278) null mutants arrest as larvae, have a severe decrease in lifespan and locomotion defects.
hrp-2 mutants show a reduction of visible D-type MNs and axonal defects, suggesting a specific role in neuron survival.
hrp-2 overexpression in D-type MNs rescued the degeneration of MNs and the defects in locomotion observed in
smn-1 silenced animals. These data suggest a specific involvement of
hrp-2 in MNs survival and in
smn-1 pathway, supporting the role of
hrp-2 as an
smn-1 modifier and as a possible therapeutic target for the disease. Further experiments are ongoing to better understand the genetic interaction between the two genes in MNs and to identify the role of mis-spliced targets in neurodegeneration.